−0.40HKD
−697.54 MHKD
805.36 MHKD
851.24 M
About INNOCARE PHARMA LTD
Sector
CEO
Jisong Cui
Headquarters
Beijing
Website
Employees (FY)
1.09 K
Founded
2015
ISIN
KYG4783B1032
FIGI
BBG00S9VV4P0
InnoCare Pharma Ltd. is a clinical-stage biopharmaceutical company. It engages in discovering, developing and commercializing drugs for the treatment of cancer and autoimmune diseases. The company was founded by Jisong Cui and Yigong Shi on November 3, 2015 and is headquartered in Beijing, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 9969 is 4.33 HKD — it has increased by 2.61% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange INNOCARE PHARMA LTD stocks are traded under the ticker 9969.
INNOCARE PHARMA LTD is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
9969 stock is 3.80% volatile and has beta coefficient of 1.46. Check out the list of the most volatile stocks — is INNOCARE PHARMA LTD there?
9969 earnings for the last quarter are −0.31 HKD per share, whereas the estimation was −0.10 HKD resulting in a −211.11% surprise. The estimated earnings for the next quarter are −0.22 HKD per share. See more details about INNOCARE PHARMA LTD earnings.
INNOCARE PHARMA LTD revenue for the last quarter amounts to 1.16 B HKD despite the estimated figure of 1.12 B HKD. In the next quarter revenue is expected to reach 175.20 M HKD.
Yes, you can track INNOCARE PHARMA LTD financials in yearly and quarterly reports right on TradingView.
9969 stock has fallen by 5.04% compared to the previous week, the month change is a 9.98% fall, over the last year INNOCARE PHARMA LTD has showed a 54.18% decrease.
9969 net income for the last quarter is −108.21 M HKD, while the quarter before that showed −117.64 M HKD of net income which accounts for 8.02% change. Track more INNOCARE PHARMA LTD financial stats to get the full picture.
Today INNOCARE PHARMA LTD has the market capitalization of 6.35 B, it has decreased by 7.69% over the last week.
No, 9969 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 9969 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNOCARE PHARMA LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 1.09 K employees. See our rating of the largest employees — is INNOCARE PHARMA LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INNOCARE PHARMA LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INNOCARE PHARMA LTD stock shows the strong sell signal. See more of INNOCARE PHARMA LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on INNOCARE PHARMA LTD future price: according to them, 9969 price has a max estimate of 12.98 HKD and a min estimate of 6.27 HKD. Read a more detailed INNOCARE PHARMA LTD forecast: see what analysts think of INNOCARE PHARMA LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNOCARE PHARMA LTD EBITDA is −670.97 M HKD, and current EBITDA margin is −83.53%. See more stats in INNOCARE PHARMA LTD financial statements.